Dosage and Administration: What Patients Need to Know
1. Recommended Dose
- The usual dose of LuciNiro is 150 mg taken twice a day—once in the morning and once in the evening.
- Each dose contains three 50 mg tablets, taken at the same time.
- You can take LuciNiro with or without food.
- Always swallow the tablets whole—do not crush, chew, or break them.
- Treatment usually continues until your tumor grows or side effects become too difficult to manage.
2. Missed Dose or Vomiting
- If you miss a dose or vomit after taking it, do not take an extra dose.
- Just take your next scheduled dose as normal.
- Let your healthcare provider know if this happens often.
3. What Happens If You Have Side Effects?
- If you experience ongoing moderate or severe side effects, your doctor may ask you to pause the treatment.
- Once your symptoms improve, you may be advised to restart at a lower dose—100 mg twice daily.
- If the same side effect happens again even after the dose is lowered, your doctor may recommend stopping treatment permanently.
Before You Start LuciNiro: Tests and Evaluations
To make sure LuciNiro is right for you, your medical team will carry out several checks. These help confirm the diagnosis, assess your health, and prepare your body for treatment.
1. Confirming the Diagnosis
- LuciNiro is used to treat desmoid tumors (also known as aggressive fibromatosis).
- You will need a biopsy of the tumor, followed by a pathology review under a microscope.
- Because this is a rare condition, a second opinion from a soft tissue tumor specialist may be helpful.
2. Imaging and Tumor Growth Check
- You’ll need an MRI or CT scan to show that the tumor is measurable and can be tracked over time.
- Doctors often look for signs that the tumor is growing, such as a 20% or more increase in size, based on criteria like RECIST 1.1.
3. Genetic or Molecular Testing (Optional)
- Some doctors may recommend testing the tumor for genetic markers, such as CTNNB1 mutations.
- While not required, this testing may help your care team better understand how the tumor might behave or respond to treatment.
4. Lab Tests to Check Your Organ Function
Before starting LuciNiro, you’ll likely have a set of baseline blood tests:
- Complete blood count (CBC) – to check red cells, white cells, and platelets
- Liver tests – including ALT, AST, and bilirubin
- Kidney tests – including creatinine and eGFR
- Electrolyte levels – especially phosphate, calcium, and magnesium
- Hormone levels – may be checked in women of childbearing age
5. Fertility and Reproductive Health
- LuciNiro may affect menstrual cycles or cause temporary loss of menstruation in some women.
- If you wish to have children in the future, ask about fertility preservation options, like egg freezing.
- Birth control is required during treatment and for a period afterward to avoid risks to a pregnancy.
6. Screening for Conditions That May Prevent Treatment
LuciNiro may not be safe or effective for everyone. Your care team will check for:
- Pregnancy or breastfeeding
- Severe liver or kidney problems
- Ongoing infections or other major health conditions
- Allergies to ingredients in the medication
7. Tracking Your Symptoms Before Treatment
- Before starting LuciNiro, your doctor will ask about how the tumor affects your daily life—such as pain, movement, or emotional well-being.
- You may be asked to complete tools like the Desmoid Symptom Scale or other patient questionnaires.
- These help measure how well the treatment is working over time.
8. Final Approval by a Specialist
- Once all tests are complete, a medical oncologist—preferably one experienced with sarcomas or rare tumors—will decide if LuciNiro is suitable for you.
- They’ll also create a plan for monitoring your health, adjusting the dose if needed, and managing side effects during treatment.
